Wall Street brokerages expect Ventas, Inc. (NYSE:VTR) to post $977.24 million in sales for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for Ventas’ earnings. The highest sales estimate is $1.00 billion and the lowest is $951.60 million. Ventas reported sales of $923.26 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 5.8%. The firm is scheduled to announce its next earnings report on Friday, February 14th.
According to Zacks, analysts expect that Ventas will report full-year sales of $3.84 billion for the current year, with estimates ranging from $3.80 billion to $3.88 billion. For the next financial year, analysts forecast that the company will report sales of $3.93 billion, with estimates ranging from $3.84 billion to $4.05 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Ventas.
Ventas (NYSE:VTR) last released its quarterly earnings data on Friday, October 25th. The real estate investment trust reported $0.23 earnings per share for the quarter, missing analysts’ consensus estimates of $0.94 by ($0.71). The firm had revenue of $983.16 million for the quarter, compared to the consensus estimate of $935.43 million. Ventas had a net margin of 12.73% and a return on equity of 4.59%. The firm’s revenue for the quarter was up 5.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.99 earnings per share.
Shares of NYSE VTR traded up $0.35 during trading on Friday, reaching $55.50. 3,800,544 shares of the company traded hands, compared to its average volume of 2,065,880. The firm has a 50 day simple moving average of $59.89 and a 200-day simple moving average of $67.64. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 1.11. The stock has a market capitalization of $20.56 billion, a PE ratio of 13.64, a P/E/G ratio of 6.10 and a beta of 0.12. Ventas has a 52-week low of $54.59 and a 52-week high of $75.40.
The company also recently announced a quarterly dividend, which will be paid on Monday, January 13th. Shareholders of record on Thursday, January 2nd will be paid a dividend of $0.7925 per share. This represents a $3.17 dividend on an annualized basis and a yield of 5.71%. The ex-dividend date of this dividend is Tuesday, December 31st. Ventas’s payout ratio is 77.89%.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in VTR. Steward Partners Investment Advisory LLC bought a new stake in Ventas during the 2nd quarter worth approximately $251,000. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Ventas by 5.6% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 324,783 shares of the real estate investment trust’s stock valued at $22,199,000 after buying an additional 17,203 shares during the last quarter. Hudock Capital Group LLC raised its position in shares of Ventas by 10.7% during the second quarter. Hudock Capital Group LLC now owns 1,558 shares of the real estate investment trust’s stock valued at $106,000 after buying an additional 151 shares during the last quarter. First Trust Advisors LP raised its position in shares of Ventas by 80.1% during the second quarter. First Trust Advisors LP now owns 159,245 shares of the real estate investment trust’s stock valued at $10,884,000 after buying an additional 70,804 shares during the last quarter. Finally, Fiduciary Financial Services of The Southwest Inc. TX raised its position in shares of Ventas by 5.9% during the second quarter. Fiduciary Financial Services of The Southwest Inc. TX now owns 17,281 shares of the real estate investment trust’s stock valued at $1,181,000 after buying an additional 958 shares during the last quarter. Institutional investors own 88.13% of the company’s stock.
Ventas, Inc, an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of approximately 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, university-based research and innovation centers, inpatient rehabilitation and long-term acute care facilities, and health systems.
Further Reading: Bond
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.